Succinylated gelatin

DB16568InvestigationalSmall molecule

Succinylated gelatin is a plasma volume expander indicated alone or in combination with blood transfusions. A medication used to replace fluid loss in the blood.

Also known as: Gelatin succinate · Gelatin, succinated · Modified fluid gelatin

Resolves to

Compound

CAS68915-24-2

Clinical / RWD

RxNorm56790

Targets

P04275VWF

What you can answer from here — as of September 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

15Clinical trialsPhase, status and sponsor resolved per trial

9Structured indicationsCondition, population, route and combination as fields, not prose

4ContraindicationsEach with its own population and attribute set

5Marketed productsAcross 2 countries and 2 labellers

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with Succinylated gelatin, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account